Page 8 - Sight Sciences Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sight Sciences (NASDAQ:SGHT – Get Rating) and Invo Bioscience (OTCMKTS:IVOB – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Insider and Institutional Ownership 50.2% of Sight Sciences shares […]

Sight Sciences, Inc. (NASDAQ:SGHT – Get Rating) was up 7.1% during trading on Monday . The company traded as high as $10.38 and last traded at $10.36. Approximately 56,480 shares traded hands during mid-day trading, a decline of 54% from the average daily volume of 122,090 shares. The stock had previously closed at $9.67. Wall […]

Sight Sciences (NASDAQ:SGHT – Get Rating) will be releasing its earnings data after the market closes on Thursday, November 10th. Analysts expect Sight Sciences to post earnings of ($0.47) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. Sight Sciences (NASDAQ:SGHT – […]